ArticleRisk management and healthcare policy2024

New Evidence of the Impact of the National Drug Price Negotiation Policy on the Availability, Utilization, and Cost of Anticancer Medicines in China: An Interrupted Time Series Study.

Xingyuan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.